| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 5.87e-07 | 21 | 65 | 4 | GO:0034987 | |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 1.14e-06 | 7 | 65 | 3 | GO:0034988 | |
| GeneOntologyMolecularFunction | methylumbelliferyl-acetate deacetylase activity | 3.12e-05 | 3 | 65 | 2 | GO:0047374 | |
| GeneOntologyMolecularFunction | carboxylesterase activity | 1.55e-04 | 6 | 65 | 2 | GO:0106435 | |
| GeneOntologyMolecularFunction | retinyl-palmitate esterase activity | 3.70e-04 | 9 | 65 | 2 | GO:0050253 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.07e-03 | 15 | 65 | 2 | GO:0010484 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.65e-06 | 8 | 65 | 3 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 2.48e-06 | 9 | 65 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 3.53e-06 | 10 | 65 | 3 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 3.53e-06 | 10 | 65 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 3.53e-06 | 10 | 65 | 3 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 4.84e-06 | 11 | 65 | 3 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 4.84e-06 | 11 | 65 | 3 | GO:0002892 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 5.66e-06 | 81 | 65 | 5 | GO:0002886 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 7.19e-06 | 148 | 65 | 6 | GO:0002444 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 8.35e-06 | 13 | 65 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.32e-05 | 15 | 65 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 1.32e-05 | 15 | 65 | 3 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.32e-05 | 15 | 65 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.97e-05 | 17 | 65 | 3 | GO:0002866 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 2.79e-05 | 19 | 65 | 3 | GO:0002883 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 5.06e-05 | 23 | 65 | 3 | GO:0002863 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 6.54e-05 | 25 | 65 | 3 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 8.28e-05 | 27 | 65 | 3 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 1.14e-04 | 30 | 65 | 3 | GO:0002888 | |
| GeneOntologyBiologicalProcess | male meiosis I | 1.26e-04 | 31 | 65 | 3 | GO:0007141 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 3.14e-04 | 42 | 65 | 3 | GO:0002675 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 3.14e-04 | 42 | 65 | 3 | GO:0002438 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 3.14e-04 | 42 | 65 | 3 | GO:0006910 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 3.61e-04 | 44 | 65 | 3 | GO:0006958 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 4.96e-04 | 49 | 65 | 3 | GO:0042771 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 5.27e-04 | 50 | 65 | 3 | GO:0045022 | |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | 6.89e-04 | 223 | 65 | 5 | GO:0050851 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 7.35e-04 | 56 | 65 | 3 | GO:0002714 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 7.35e-04 | 56 | 65 | 3 | GO:0098927 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 7.35e-04 | 56 | 65 | 3 | GO:0002891 | |
| GeneOntologyBiologicalProcess | male meiotic nuclear division | 8.99e-04 | 60 | 65 | 3 | GO:0007140 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 9.28e-04 | 359 | 65 | 6 | GO:0002429 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 9.44e-04 | 61 | 65 | 3 | GO:0002861 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 9.89e-04 | 62 | 65 | 3 | GO:0002455 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 1.07e-05 | 14 | 66 | 3 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.98e-05 | 17 | 66 | 3 | GO:0042571 | |
| MousePheno | absent memory B cells | 1.94e-07 | 4 | 52 | 3 | MP:0008094 | |
| MousePheno | decreased memory B cell number | 4.01e-06 | 9 | 52 | 3 | MP:0008729 | |
| MousePheno | decreased IgG2c level | 7.84e-06 | 11 | 52 | 3 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 7.84e-06 | 11 | 52 | 3 | MP:0008093 | |
| MousePheno | abnormal memory B cell morphology | 1.72e-05 | 14 | 52 | 3 | MP:0002440 | |
| MousePheno | decreased body temperature | 2.14e-05 | 91 | 52 | 5 | MP:0005534 | |
| MousePheno | abnormal plasma cell differentiation | 2.14e-05 | 15 | 52 | 3 | MP:0008099 | |
| MousePheno | enhanced humoral immune response | 3.18e-05 | 17 | 52 | 3 | MP:0020155 | |
| MousePheno | abnormal IgG2c level | 6.16e-05 | 21 | 52 | 3 | MP:0020178 | |
| MousePheno | abnormal body temperature | 1.51e-04 | 137 | 52 | 5 | MP:0005535 | |
| MousePheno | increased germinal center B cell number | 2.03e-04 | 31 | 52 | 3 | MP:0008177 | |
| Domain | hSH3 | 3.57e-05 | 3 | 65 | 2 | IPR029294 | |
| Domain | hSH3 | 3.57e-05 | 3 | 65 | 2 | PF14603 | |
| Domain | Ski_Sno | 2.48e-04 | 7 | 65 | 2 | PF02437 | |
| Domain | - | 2.48e-04 | 7 | 65 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 2.48e-04 | 7 | 65 | 2 | IPR003380 | |
| Domain | Carboxylesterase_B_AS | 3.29e-04 | 8 | 65 | 2 | IPR019826 | |
| Domain | CARBOXYLESTERASE_B_1 | 3.29e-04 | 8 | 65 | 2 | PS00122 | |
| Domain | DNA-bd_dom_put | 6.43e-04 | 11 | 65 | 2 | IPR009061 | |
| Domain | C1-set | 8.79e-04 | 54 | 65 | 3 | PF07654 | |
| Domain | Carboxylesterase_B_CS | 9.08e-04 | 13 | 65 | 2 | IPR019819 | |
| Domain | IGc1 | 9.78e-04 | 56 | 65 | 3 | SM00407 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.06e-03 | 14 | 65 | 2 | PS00941 | |
| Domain | uDENN | 1.06e-03 | 14 | 65 | 2 | SM00800 | |
| Domain | COesterase | 1.06e-03 | 14 | 65 | 2 | PF00135 | |
| Domain | CarbesteraseB | 1.06e-03 | 14 | 65 | 2 | IPR002018 | |
| Domain | Ig_C1-set | 1.08e-03 | 58 | 65 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.08e-03 | 58 | 65 | 3 | IPR003006 | |
| Domain | IG_MHC | 1.19e-03 | 60 | 65 | 3 | PS00290 | |
| Domain | uDENN | 1.22e-03 | 15 | 65 | 2 | PF03456 | |
| Domain | UDENN | 1.39e-03 | 16 | 65 | 2 | PS50946 | |
| Domain | DDENN | 1.39e-03 | 16 | 65 | 2 | PS50947 | |
| Domain | DENN | 1.39e-03 | 16 | 65 | 2 | SM00799 | |
| Domain | dDENN | 1.39e-03 | 16 | 65 | 2 | SM00801 | |
| Domain | DENN | 1.39e-03 | 16 | 65 | 2 | PF02141 | |
| Domain | dDENN_dom | 1.39e-03 | 16 | 65 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.39e-03 | 16 | 65 | 2 | IPR005113 | |
| Domain | dDENN | 1.39e-03 | 16 | 65 | 2 | PF03455 | |
| Domain | DENN | 1.39e-03 | 16 | 65 | 2 | PS50211 | |
| Domain | DENN_dom | 1.39e-03 | 16 | 65 | 2 | IPR001194 | |
| Domain | RUN | 1.76e-03 | 18 | 65 | 2 | SM00593 | |
| Domain | RUN | 1.96e-03 | 19 | 65 | 2 | PS50826 | |
| Domain | RUN | 1.96e-03 | 19 | 65 | 2 | PF02759 | |
| Domain | Run_dom | 1.96e-03 | 19 | 65 | 2 | IPR004012 | |
| Domain | PHD | 2.27e-03 | 75 | 65 | 3 | PF00628 | |
| Domain | PLAT | 2.40e-03 | 21 | 65 | 2 | PS50095 | |
| Domain | - | 2.40e-03 | 21 | 65 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.40e-03 | 21 | 65 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.40e-03 | 21 | 65 | 2 | IPR001024 | |
| Domain | Znf_PHD-finger | 2.63e-03 | 79 | 65 | 3 | IPR019787 | |
| Domain | PHD | 3.69e-03 | 89 | 65 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.93e-03 | 91 | 65 | 3 | IPR001965 | |
| Domain | ETS_DOMAIN_1 | 4.25e-03 | 28 | 65 | 2 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 4.25e-03 | 28 | 65 | 2 | PS00346 | |
| Domain | ETS | 4.25e-03 | 28 | 65 | 2 | SM00413 | |
| Domain | Ets_dom | 4.25e-03 | 28 | 65 | 2 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 4.25e-03 | 28 | 65 | 2 | PS50061 | |
| Domain | Ets | 4.25e-03 | 28 | 65 | 2 | PF00178 | |
| Domain | ZF_PHD_2 | 4.43e-03 | 95 | 65 | 3 | PS50016 | |
| Domain | ATPase_AAA_CS | 4.56e-03 | 29 | 65 | 2 | IPR003960 | |
| Domain | ZF_PHD_1 | 4.57e-03 | 96 | 65 | 3 | PS01359 | |
| Domain | AAA | 6.23e-03 | 34 | 65 | 2 | PS00674 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 4.23e-06 | 12 | 39 | 3 | M39611 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.67e-04 | 39 | 39 | 3 | MM17212 | |
| Pathway | WP_PHASE_I_BIOTRANSFORMATIONS_NONP450 | 2.07e-04 | 8 | 39 | 2 | M39342 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.56e-04 | 45 | 39 | 3 | MM15694 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 3.11e-04 | 48 | 39 | 3 | MM17214 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.72e-04 | 51 | 39 | 3 | M17726 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 4.40e-04 | 54 | 39 | 3 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.90e-04 | 56 | 39 | 3 | MM14815 | |
| Pubmed | 1.88e-10 | 6 | 67 | 4 | 27769169 | ||
| Pubmed | Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. | 4.38e-10 | 7 | 67 | 4 | 30538335 | |
| Pubmed | 8.75e-10 | 8 | 67 | 4 | 32601467 | ||
| Pubmed | 4.11e-09 | 11 | 67 | 4 | 34586363 | ||
| Pubmed | Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction. | 4.11e-09 | 11 | 67 | 4 | 29562201 | |
| Pubmed | Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. | 6.83e-09 | 3 | 67 | 3 | 20195289 | |
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 10452915 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 2.73e-08 | 4 | 67 | 3 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 2.73e-08 | 4 | 67 | 3 | 6801765 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 2.73e-08 | 4 | 67 | 3 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 2.73e-08 | 4 | 67 | 3 | 11812141 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6794027 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6306571 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 2.73e-08 | 4 | 67 | 3 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 2.73e-08 | 4 | 67 | 3 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 2.73e-08 | 4 | 67 | 3 | 19050247 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 1672339 | ||
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 2.73e-08 | 4 | 67 | 3 | 30287618 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 7892607 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 4565406 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 2.73e-08 | 4 | 67 | 3 | 1713710 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 2.73e-08 | 4 | 67 | 3 | 9103199 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 2.73e-08 | 4 | 67 | 3 | 98524 | |
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 2.73e-08 | 4 | 67 | 3 | 25363774 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 20621099 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 38268239 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 2.73e-08 | 4 | 67 | 3 | 12414967 | |
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 2.73e-08 | 4 | 67 | 3 | 6799207 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6787604 | ||
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 2.73e-08 | 4 | 67 | 3 | 8438159 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 4098598 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 2.73e-08 | 4 | 67 | 3 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 2.73e-08 | 4 | 67 | 3 | 6803173 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6170065 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6264445 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 2.73e-08 | 4 | 67 | 3 | 19703988 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 2.73e-08 | 4 | 67 | 3 | 25867470 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 1542303 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 2.73e-08 | 4 | 67 | 3 | 9126488 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 2.73e-08 | 4 | 67 | 3 | 6767246 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 12051834 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 8683112 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 8452816 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 2.73e-08 | 4 | 67 | 3 | 807855 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 4166666 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 26201558 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6249338 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 2.73e-08 | 4 | 67 | 3 | 19592272 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 10720538 | ||
| Pubmed | Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. | 2.73e-08 | 4 | 67 | 3 | 18794728 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 4831970 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 7439686 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 24752300 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 15699144 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6278424 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 35133976 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 8099342 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 2513486 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 36763580 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 2.73e-08 | 4 | 67 | 3 | 32006024 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 12209645 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 2.73e-08 | 4 | 67 | 3 | 3921826 | |
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 2.73e-08 | 4 | 67 | 3 | 117549 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 116231 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 2.73e-08 | 4 | 67 | 3 | 26683050 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 25451975 | ||
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 2.73e-08 | 4 | 67 | 3 | 6766534 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 6.81e-08 | 5 | 67 | 3 | 35044826 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 6.81e-08 | 5 | 67 | 3 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 6.81e-08 | 5 | 67 | 3 | 6770027 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 6.81e-08 | 5 | 67 | 3 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 6.81e-08 | 5 | 67 | 3 | 26620759 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 32640012 | ||
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 6.81e-08 | 5 | 67 | 3 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 6.81e-08 | 5 | 67 | 3 | 20031218 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 6.81e-08 | 5 | 67 | 3 | 34539636 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 3031474 | ||
| Pubmed | A novel allele for inducible Cre expression in germinal center B cells. | 6.81e-08 | 5 | 67 | 3 | 30359469 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 33025844 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 6.81e-08 | 5 | 67 | 3 | 6798155 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 9834201 | ||
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 6.81e-08 | 5 | 67 | 3 | 24548411 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 103631 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 33163250 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 37310381 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 36853944 | ||
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 6.81e-08 | 5 | 67 | 3 | 6781756 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 6.81e-08 | 5 | 67 | 3 | 9743367 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 23423996 | ||
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 6.81e-08 | 5 | 67 | 3 | 16301663 | |
| Interaction | TLE3 interactions | PYGO2 GSE1 BRCA2 BAZ2B MCM3AP PROSER1 FEV GPATCH8 BCOR KHDC4 KDM1A | 2.53e-08 | 376 | 64 | 11 | int:TLE3 |
| Interaction | SOX5 interactions | 1.25e-05 | 162 | 64 | 6 | int:SOX5 | |
| Cytoband | 14q32.33 | 3.55e-04 | 228 | 67 | 4 | 14q32.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q12 | 4.73e-04 | 103 | 67 | 3 | chr16q12 | |
| Cytoband | 16q22.2 | 4.76e-04 | 22 | 67 | 2 | 16q22.2 | |
| Cytoband | 16q12.2 | 6.67e-04 | 26 | 67 | 2 | 16q12.2 | |
| Cytoband | 16q24.1 | 1.08e-03 | 33 | 67 | 2 | 16q24.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.09e-03 | 797 | 67 | 6 | chr19p13 | |
| GeneFamily | Carboxylesterases | 6.87e-05 | 5 | 48 | 2 | 461 | |
| GeneFamily | PHD finger proteins | 1.75e-03 | 90 | 48 | 3 | 88 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.99e-03 | 25 | 48 | 2 | 504 | |
| GeneFamily | ETS transcription factor family | 2.50e-03 | 28 | 48 | 2 | 534 | |
| GeneFamily | Ankyrin repeat domain containing | 3.84e-03 | 242 | 48 | 4 | 403 | |
| GeneFamily | AAA ATPases | 8.73e-03 | 53 | 48 | 2 | 413 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 1.34e-02 | 187 | 48 | 3 | 349 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 4.46e-06 | 43 | 67 | 4 | MM799 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS | 2.05e-05 | 21 | 67 | 3 | M39281 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 3.32e-05 | 143 | 67 | 5 | MM1056 | |
| Coexpression | ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN | 3.98e-05 | 26 | 67 | 3 | M8224 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#4 | 4.82e-05 | 24 | 63 | 3 | Arv_SC-H9hpx_500_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.93e-05 | 74 | 63 | 4 | Arv_SC-HD_1000_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.69e-05 | 76 | 63 | 4 | Arv_SC_fibroblast_1000_K4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-08 | 139 | 67 | 6 | 693ca81f5831b63fe6148ac755631e09f67d0ebf | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-07 | 179 | 67 | 6 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-07 | 179 | 67 | 6 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-07 | 179 | 67 | 6 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.39e-07 | 183 | 67 | 6 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 3.85e-07 | 187 | 67 | 6 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.97e-07 | 188 | 67 | 6 | 6f53bcd4caab2fc961af799039ea5c3ddae56781 | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_memory|COVID-19_Severe / Disease group, lineage and cell class | 4.22e-07 | 190 | 67 | 6 | b6510c419a15ed049c0a0a6a6697b643668741c3 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-07 | 190 | 67 | 6 | 95b9334573eefb132daaa9371377ad60232006ae | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-07 | 192 | 67 | 6 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | Healthy_donor-B_intermediate|World / disease group, cell group and cell class (v2) | 4.49e-07 | 192 | 67 | 6 | f77007b284e11f8654ad599eef929df7c6c4ebf0 | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.06e-07 | 196 | 67 | 6 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.22e-07 | 197 | 67 | 6 | 43e576bd6997915d21137e233e36984eba31f637 | |
| ToppCell | VE-mDC2-|VE / Condition, Cell_class and T cell subcluster | 5.22e-07 | 197 | 67 | 6 | 6629588819ec31a7e4f33b94b8c035145a5f6c17 | |
| ToppCell | VE-mDC2|VE / Condition, Cell_class and T cell subcluster | 5.22e-07 | 197 | 67 | 6 | e3172102ad17c92c3038cad37bf933eb04351048 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory|COVID-19_Severe / Disease, condition lineage and cell class | 5.54e-07 | 199 | 67 | 6 | 24c05faa825c9d55279956469862440f9914a280 | |
| ToppCell | Sigmoid-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 5.70e-07 | 200 | 67 | 6 | 2071a71b6fba403f55becddc0434d56a0b598c8e | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-06 | 128 | 67 | 5 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-06 | 142 | 67 | 5 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-06 | 142 | 67 | 5 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.67e-06 | 145 | 67 | 5 | 34cff6df39ff05995041f0c231c60a50ad1a0c1c | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|normal_Lung / Location, Cell class and cell subclass | 4.19e-06 | 159 | 67 | 5 | f89fc18966d9b9b33e81e7b9eb3ec3420c20ff43 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 4.32e-06 | 160 | 67 | 5 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 4.45e-06 | 161 | 67 | 5 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 4.73e-06 | 163 | 67 | 5 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 5.02e-06 | 165 | 67 | 5 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | Control-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 5.48e-06 | 168 | 67 | 5 | d7118d39253ed9790908b850088ebfc5a86f4065 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 5.80e-06 | 170 | 67 | 5 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.80e-06 | 170 | 67 | 5 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_intermediate|ICU-SEP / Disease, Lineage and Cell Type | 5.97e-06 | 171 | 67 | 5 | 2e44bf6f3d90193e7cadcac48bb852bd632a81bc | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.32e-06 | 173 | 67 | 5 | 9082ad77b44f65b72094df6e502cce81b62fe81a | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 6.87e-06 | 176 | 67 | 5 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|World / disease group, cell group and cell class (v2) | 7.06e-06 | 177 | 67 | 5 | 057871e211c6508b2a679d391f3cf0ac7ccfc628 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.45e-06 | 179 | 67 | 5 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 7.66e-06 | 180 | 67 | 5 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 7.87e-06 | 181 | 67 | 5 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.87e-06 | 181 | 67 | 5 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 7.87e-06 | 181 | 67 | 5 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | Healthy-B_memory|Healthy / disease group, cell group and cell class | 7.87e-06 | 181 | 67 | 5 | 7b903076efb90026b9845af0c7a840901451193a | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.87e-06 | 181 | 67 | 5 | 768d14c452192f92fa557ae59e84c43436f575f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-06 | 181 | 67 | 5 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | (2)_B_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.08e-06 | 182 | 67 | 5 | 8fe9b3a82159a388ffb642ac4f6aff05b8b5f944 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.08e-06 | 182 | 67 | 5 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | URO-Lymphocyte-B-B_memory|URO / Disease, Lineage and Cell Type | 8.08e-06 | 182 | 67 | 5 | 8ffdf15230349ad53fe15bb467724d28c5a05bf6 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_memory|Leuk-UTI / Disease, Lineage and Cell Type | 8.30e-06 | 183 | 67 | 5 | f7a5daec3e8484c7071164a09e9c961fe64d9f81 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.30e-06 | 183 | 67 | 5 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, Lineage and Cell Type | 8.30e-06 | 183 | 67 | 5 | c6d1d0779c46e08d2235b6dd342a7ec25911864c | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 8.30e-06 | 183 | 67 | 5 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.30e-06 | 183 | 67 | 5 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 8.30e-06 | 183 | 67 | 5 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.52e-06 | 184 | 67 | 5 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 8.52e-06 | 184 | 67 | 5 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | Healthy/Control-B_memory|World / Disease group and Cell class | 8.52e-06 | 184 | 67 | 5 | 9e1879d86b535ede9b47deb0752e291f987a5d5e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 8.52e-06 | 184 | 67 | 5 | ffc9eec123de34a4f17ed27fe4f0a1b3cb84697f | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.52e-06 | 184 | 67 | 5 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.52e-06 | 184 | 67 | 5 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.52e-06 | 184 | 67 | 5 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.75e-06 | 185 | 67 | 5 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | tumor_Lung-B_lymphocytes|tumor_Lung / Location, Cell class and cell subclass | 8.98e-06 | 186 | 67 | 5 | a54b368d7921185c583e35b532a6898c5486c2fc | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.98e-06 | 186 | 67 | 5 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.98e-06 | 186 | 67 | 5 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 9.21e-06 | 187 | 67 | 5 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | Control-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class | 9.45e-06 | 188 | 67 | 5 | ba4245de3bee29118abab57c4fce60b2007a189c | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_memory|ICU-SEP / Disease, Lineage and Cell Type | 9.45e-06 | 188 | 67 | 5 | b6d81be72bbd72a68722ab51d1a72c436ef9bc17 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.45e-06 | 188 | 67 | 5 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | (1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 9.45e-06 | 188 | 67 | 5 | 642a334f2d5b6dc9df4a9fa0558833bd37bd3c58 | |
| ToppCell | (10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 9.45e-06 | 188 | 67 | 5 | fa1346902021c3a6557555ada0fd37b29cf9d5ec | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.45e-06 | 188 | 67 | 5 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | Healthy/Control-B_memory|Healthy/Control / Disease group and Cell class | 9.45e-06 | 188 | 67 | 5 | 3aff07f77b2b15e7a30e47b30115178abe64474e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.45e-06 | 188 | 67 | 5 | 9256c5f45c97df209bb9c322c3b557d4f726a333 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.70e-06 | 189 | 67 | 5 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.70e-06 | 189 | 67 | 5 | ac0203f17b481d608587113ea2de0f383b29ed27 | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 9.95e-06 | 190 | 67 | 5 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | ICU-SEP-Lymphocyte-B|ICU-SEP / Disease, Lineage and Cell Type | 9.95e-06 | 190 | 67 | 5 | a861506520780932b4630fa285c1e4a77134a505 | |
| ToppCell | Control-Lymphoid_B|Control / Disease group, lineage and cell class | 1.02e-05 | 191 | 67 | 5 | 0a760cd3a48c487ec899adb882fddea8914cfe0c | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 1.02e-05 | 191 | 67 | 5 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-05 | 191 | 67 | 5 | 03f6da73e7b706252d2096507222229c4101a27b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-05 | 191 | 67 | 5 | 578b58782e816ecaeabfbc616ceb1dcd53ee428b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 191 | 67 | 5 | 22134a2c1a92208bc1629a620ce73a56502613c2 | |
| ToppCell | severe_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 1.02e-05 | 191 | 67 | 5 | 3b57e353b74ebc866d0e11deeba31fa764c42325 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 191 | 67 | 5 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.02e-05 | 191 | 67 | 5 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-05 | 192 | 67 | 5 | f9f64ad7bab1433e9a45adb7db7f43ce3f591b47 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.05e-05 | 192 | 67 | 5 | 4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5 | |
| ToppCell | (100)_CD19+_Naive_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.05e-05 | 192 | 67 | 5 | ae7e6ed7b6cc1dd45bc0547783515beecad7792a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-05 | 192 | 67 | 5 | debd471f61cf3606b8e9c246add0be5df601af7f | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 1.05e-05 | 192 | 67 | 5 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-05 | 192 | 67 | 5 | 314f74dd3c6d94839eed05b9a1a398217ef78029 | |
| ToppCell | Healthy/Control-B_intermediate|World / Disease group and Cell class | 1.05e-05 | 192 | 67 | 5 | 2266aa695955f5d885708e6bc0d5a8827c306223 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 192 | 67 | 5 | e33579a20ca86dcaf02c97273681ba5eee7561b8 | |
| ToppCell | VE-naiveBc-|VE / Condition, Cell_class and T cell subcluster | 1.05e-05 | 192 | 67 | 5 | bca2aec4811627225fccd92abe2f3b1ba729c9ce | |
| ToppCell | VE-naiveBc|VE / Condition, Cell_class and T cell subcluster | 1.05e-05 | 192 | 67 | 5 | 87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1 | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 1.07e-05 | 193 | 67 | 5 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.07e-05 | 193 | 67 | 5 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-05 | 193 | 67 | 5 | 8f1d6024ef092923321e6efd441b8d476db70aed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 193 | 67 | 5 | de0213f2105b814f38ffbfd004ea7603230eed68 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 193 | 67 | 5 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | Healthy_donor-B_intermediate|Healthy_donor / disease group, cell group and cell class (v2) | 1.07e-05 | 193 | 67 | 5 | e2be57bf3cbbbbff64853f06b9c11b136f73eea7 | |
| ToppCell | MS-naiveBc|MS / Condition, Cell_class and T cell subcluster | 1.10e-05 | 194 | 67 | 5 | aa4aa0a61275610054b583f60d5d41ecc4f88a0d | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-05 | 194 | 67 | 5 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| Drug | chloromalonic acid | 9.29e-08 | 4 | 66 | 3 | CID000011751 | |
| Drug | fluazifop-butyl | 6.52e-06 | 13 | 66 | 3 | CID000050897 | |
| Drug | carboxin | 6.63e-06 | 42 | 66 | 4 | CID000021307 | |
| Drug | AC1M5V1J | 8.28e-06 | 2 | 66 | 2 | CID002385967 | |
| Drug | 5-iodoisatin | 8.28e-06 | 2 | 66 | 2 | CID000088695 | |
| Drug | 5-chloro-7-methylisatin | 8.28e-06 | 2 | 66 | 2 | CID000366710 | |
| Drug | I08-742 | 8.28e-06 | 2 | 66 | 2 | CID002786143 | |
| Drug | 3,3'-dimethoxybenzil | 8.28e-06 | 2 | 66 | 2 | CID000123493 | |
| Drug | tolserine | 8.28e-06 | 2 | 66 | 2 | ctd:C412047 | |
| Drug | NSC-379518 | 8.28e-06 | 2 | 66 | 2 | CID000137905 | |
| Drug | DNC005462 | 8.28e-06 | 2 | 66 | 2 | CID011437501 | |
| Drug | 2-nitrophenylacetic acid | 8.28e-06 | 2 | 66 | 2 | ctd:C119971 | |
| Drug | aceanthrenequinone | 8.28e-06 | 2 | 66 | 2 | CID000316765 | |
| Drug | 7-trifluoromethylisatin | 8.28e-06 | 2 | 66 | 2 | CID000604575 | |
| Drug | DNC005463 | 8.28e-06 | 2 | 66 | 2 | CID011392969 | |
| Drug | 5-chloroisatin | 8.28e-06 | 2 | 66 | 2 | CID000087203 | |
| Drug | AC1MS20N | 8.28e-06 | 2 | 66 | 2 | CID003527426 | |
| Drug | 4-Chlorobenzil | 8.28e-06 | 2 | 66 | 2 | CID000089801 | |
| Drug | 9-amino-6-chloro-2-methoxyacridine | 8.28e-06 | 2 | 66 | 2 | ctd:C010847 | |
| Drug | 4,5-dichloro-1H-indole-2,3-dione | 8.28e-06 | 2 | 66 | 2 | CID005139980 | |
| Drug | 1,2-bis(4-nitrophenyl)ethane-1,2-dione | 8.28e-06 | 2 | 66 | 2 | CID001812008 | |
| Drug | p-methylbenzil | 8.28e-06 | 2 | 66 | 2 | CID000075511 | |
| Drug | AC1Q27R1 | 8.28e-06 | 2 | 66 | 2 | CID000087502 | |
| Drug | 4-amino-2,6-dimethylphenol | 8.28e-06 | 2 | 66 | 2 | CID000082667 | |
| Drug | 2-chloro-3',4'-dimeth-oxy-benzil | 8.28e-06 | 2 | 66 | 2 | CID000092036 | |
| Drug | AC1M2MWF | 8.28e-06 | 2 | 66 | 2 | CID002147394 | |
| Drug | 4,7-dichloroisatin | 8.28e-06 | 2 | 66 | 2 | CID002734793 | |
| Drug | 4,6-dichloro-1h-indole-2,3-dione | 8.28e-06 | 2 | 66 | 2 | CID000251908 | |
| Drug | d18-75 | 8.28e-06 | 2 | 66 | 2 | CID000076996 | |
| Drug | AC1LWPKX | 8.28e-06 | 2 | 66 | 2 | CID001755771 | |
| Drug | AC1Q2DS8 | 8.28e-06 | 2 | 66 | 2 | CID002427416 | |
| Drug | 1,2-dicyclohexylethane-1,2-dione | 8.28e-06 | 2 | 66 | 2 | CID011806279 | |
| Drug | DP00565 | 8.28e-06 | 2 | 66 | 2 | CID002777298 | |
| Drug | NSC 408976 | 8.28e-06 | 2 | 66 | 2 | CID000101375 | |
| Drug | 2,2'-Dichlorobenzil | 8.28e-06 | 2 | 66 | 2 | CID000089076 | |
| Drug | diethyl fluoromalonate | 8.28e-06 | 2 | 66 | 2 | CID000012702 | |
| Drug | anisil | 8.28e-06 | 2 | 66 | 2 | CID000071043 | |
| Drug | 6-chloro-7-methyl-1H-indole-2,3-dione | 8.28e-06 | 2 | 66 | 2 | CID004513067 | |
| Drug | 5,7-dichloroisatin | 8.28e-06 | 2 | 66 | 2 | CID000080771 | |
| Drug | 4-chloroisatin | 8.28e-06 | 2 | 66 | 2 | CID000096047 | |
| Drug | 6-O-monoacetylmorphine | 8.28e-06 | 2 | 66 | 2 | ctd:C026979 | |
| Drug | p-methoxybenzil | 8.28e-06 | 2 | 66 | 2 | CID000031494 | |
| Drug | AC1N9FPX | 8.28e-06 | 2 | 66 | 2 | CID004384851 | |
| Drug | NNMP | 8.28e-06 | 2 | 66 | 2 | CID000146767 | |
| Drug | aniracetam | 8.28e-06 | 2 | 66 | 2 | ctd:C036466 | |
| Drug | AC1Q24Z2 | 8.28e-06 | 2 | 66 | 2 | CID004338240 | |
| Drug | 4-nitrobenzil | 8.28e-06 | 2 | 66 | 2 | CID000283893 | |
| Drug | 1-benzyl-1h-indole-2,3-dione | 8.28e-06 | 2 | 66 | 2 | CID000264734 | |
| Drug | prolyl-beta-naphthylamide | 8.28e-06 | 2 | 66 | 2 | CID000167505 | |
| Drug | chloroisatin | 8.28e-06 | 2 | 66 | 2 | CID000137777 | |
| Drug | 5-(Trifluoro-meth-oxy)isatin | 8.28e-06 | 2 | 66 | 2 | CID002732752 | |
| Drug | 4-chloro-7-methyl-1h-indole-2,3-dione | 8.28e-06 | 2 | 66 | 2 | CID001810509 | |
| Drug | hostacain | 8.28e-06 | 2 | 66 | 2 | CID000022378 | |
| Drug | acetaldophosphamide | 8.28e-06 | 2 | 66 | 2 | CID000163905 | |
| Drug | phenethylcymserine | 8.28e-06 | 2 | 66 | 2 | ctd:C576198 | |
| Drug | 4,4'-Difluorobenzil | 8.28e-06 | 2 | 66 | 2 | CID000123072 | |
| Drug | 5,6-dichloro-1H-indole-2,3-dione | 8.28e-06 | 2 | 66 | 2 | CID011009341 | |
| Drug | 4,4'-Dichlorobenzil | 8.28e-06 | 2 | 66 | 2 | CID000018946 | |
| Drug | 4-nitrophenylacetic acid | 8.28e-06 | 2 | 66 | 2 | ctd:C118008 | |
| Drug | AC1MBV04 | 8.28e-06 | 2 | 66 | 2 | CID002731732 | |
| Drug | 1-laurylisatin | 8.28e-06 | 2 | 66 | 2 | CID001897797 | |
| Drug | 1-cetylisatin | 8.28e-06 | 2 | 66 | 2 | CID003772674 | |
| Drug | AC1N4VNK | 8.28e-06 | 2 | 66 | 2 | CID004135273 | |
| Drug | versicolorin A | 2.18e-05 | 19 | 66 | 3 | CID000099940 | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 2.43e-05 | 199 | 66 | 6 | 6816_UP | |
| Drug | ethyl pentanoate | 2.48e-05 | 3 | 66 | 2 | CID000010882 | |
| Drug | 1-(2-bromoethyl)-1H-indole-2,3-dione | 2.48e-05 | 3 | 66 | 2 | CID003542734 | |
| Drug | 6-bromo-5-methyl-1H-indole-2,3-dione | 2.48e-05 | 3 | 66 | 2 | CID001718647 | |
| Drug | AC1MBTQK | 2.48e-05 | 3 | 66 | 2 | CID002731127 | |
| Drug | 2-tridecanol | 2.48e-05 | 3 | 66 | 2 | CID000015449 | |
| Drug | indandione | 2.48e-05 | 3 | 66 | 2 | CID000123358 | |
| Drug | 5'-deoxy-5-fluorocytidine | 2.48e-05 | 3 | 66 | 2 | ctd:C418208 | |
| Drug | diphenyl methyl phosphate | 2.48e-05 | 3 | 66 | 2 | CID000008291 | |
| Drug | 5-bromoindoxyl acetate | 2.48e-05 | 3 | 66 | 2 | CID000087075 | |
| Drug | riboflavin-5'-monobutyrate | 2.48e-05 | 3 | 66 | 2 | CID000189057 | |
| Drug | tributyl phosphite | 2.48e-05 | 3 | 66 | 2 | CID000007623 | |
| Drug | 2,2-dimethylpropyl methylphosphonofluoridate | 2.48e-05 | 3 | 66 | 2 | CID000574378 | |
| Drug | 7-Chloro-indoline-2,3-dione | 2.48e-05 | 3 | 66 | 2 | CID000344135 | |
| Drug | AC1L7MWY | 2.48e-05 | 3 | 66 | 2 | CID000313189 | |
| Drug | bis(tBu-SATE)PMEA | 2.48e-05 | 3 | 66 | 2 | CID000464177 | |
| Drug | cyclohexyl hexadecanoate | 2.48e-05 | 3 | 66 | 2 | CID000074288 | |
| Drug | AC1Q2MLF | 2.48e-05 | 3 | 66 | 2 | CID002305233 | |
| Drug | 1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydroacridine | 2.48e-05 | 3 | 66 | 2 | ctd:C122128 | |
| Drug | Methoxypropanol acetate | 2.48e-05 | 3 | 66 | 2 | CID003033863 | |
| Drug | AC1MBVDR | 2.48e-05 | 3 | 66 | 2 | CID002731902 | |
| Drug | AC1MBVDX | 2.48e-05 | 3 | 66 | 2 | CID002731904 | |
| Drug | 5-bromisatin | 2.48e-05 | 3 | 66 | 2 | CID000006889 | |
| Drug | nordalbergin | 2.48e-05 | 3 | 66 | 2 | CID005320203 | |
| Drug | NACPC | 2.48e-05 | 3 | 66 | 2 | CID000175510 | |
| Drug | 6-chloroisatin | 2.48e-05 | 3 | 66 | 2 | CID000241331 | |
| Drug | monomethyl adipate | 2.48e-05 | 3 | 66 | 2 | CID000012328 | |
| Drug | NSC-127077 | 2.48e-05 | 3 | 66 | 2 | CID000277990 | |
| Drug | NNMBz | 2.48e-05 | 3 | 66 | 2 | CID000124353 | |
| Drug | AC1Q6FL6 | 2.48e-05 | 3 | 66 | 2 | CID003821945 | |
| Drug | ACE co | 2.48e-05 | 3 | 66 | 2 | CID000163966 | |
| Drug | acetaldoifosphamide | 2.48e-05 | 3 | 66 | 2 | CID000131513 | |
| Drug | N-methylisatin | 2.48e-05 | 3 | 66 | 2 | CID000016358 | |
| Drug | AC1Q2IW1 | 2.48e-05 | 3 | 66 | 2 | CID001713189 | |
| Drug | AC1MBV07 | 2.48e-05 | 3 | 66 | 2 | CID002731733 | |
| Drug | AC1Q6FOF | 2.48e-05 | 3 | 66 | 2 | CID003114312 | |
| Disease | insulin growth factor-like family member 4 measurement | 4.78e-06 | 2 | 65 | 2 | EFO_0801701 | |
| Disease | neural cell adhesion molecule 1 measurement | 4.78e-06 | 2 | 65 | 2 | EFO_0801826 | |
| Disease | secretoglobin family 1C member 1 measurement | 1.43e-05 | 3 | 65 | 2 | EFO_0802041 | |
| Disease | ameloblastin measurement | 1.43e-05 | 3 | 65 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 1.43e-05 | 3 | 65 | 2 | EFO_0801866 | |
| Disease | trem-like transcript 4 protein measurement | 2.86e-05 | 4 | 65 | 2 | EFO_0802160 | |
| Disease | di-N-acetylchitobiase measurement | 2.86e-05 | 4 | 65 | 2 | EFO_0801524 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 2.86e-05 | 4 | 65 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 2.86e-05 | 4 | 65 | 2 | EFO_0802027 | |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 4.76e-05 | 5 | 65 | 2 | EFO_0801901 | |
| Disease | protein shisa-3 homolog measurement | 4.76e-05 | 5 | 65 | 2 | EFO_0801964 | |
| Disease | complement C1q subcomponent measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0008089 | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0801422 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0801810 | |
| Disease | inducible T-cell costimulator measurement | 9.96e-05 | 7 | 65 | 2 | EFO_0021967 | |
| Disease | axin-2 measurement | 2.13e-04 | 10 | 65 | 2 | EFO_0801400 | |
| Disease | hormone measurement, thyroxine measurement | 2.59e-04 | 11 | 65 | 2 | EFO_0004730, EFO_0005130 | |
| Disease | HETE measurement | 3.52e-04 | 62 | 65 | 3 | EFO_0801166 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 3.67e-04 | 13 | 65 | 2 | EFO_0010617 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 7.98e-04 | 19 | 65 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | emphysema pattern measurement | 7.98e-04 | 19 | 65 | 2 | EFO_0005850 | |
| Disease | Anophthalmia-microphthalmia syndrome | 9.77e-04 | 21 | 65 | 2 | cv:C5680330 | |
| Disease | platelet crit | 1.13e-03 | 952 | 65 | 8 | EFO_0007985 | |
| Disease | Bilateral Wilms Tumor | 1.87e-03 | 29 | 65 | 2 | C2930471 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVAIFLGIPFAKPPL | 46 | P23141 | |
| LGIPFAKPPLGPLRF | 51 | P23141 | |
| FLGAPFLSPGPRSPL | 826 | Q8IZF5 | |
| PGPGPPFTLKPRVFL | 321 | Q8NCV1 | |
| NLGSLQPLPPGFKRF | 66 | Q86U02 | |
| RLPPGFPVKIEIPLF | 401 | Q6ZTN6 | |
| LLGRFCGKVPPPPFT | 101 | Q5VXM1 | |
| GLFKRLGIPGPTPLP | 31 | P20815 | |
| GATFFPPLLGIPPLF | 126 | Q9UIF8 | |
| YKLPAGLAPLPFPGL | 161 | Q99581 | |
| PFLPGPGPFLAELEK | 666 | Q14687 | |
| GLFPPLCPFLGFRPE | 6 | Q9HB09 | |
| GVPAAPVLPFGLTPK | 756 | O60610 | |
| LAPKPGLPYGLPTGR | 696 | Q6W2J9 | |
| KIPDFFIPPKLPSGP | 46 | Q8TF44 | |
| LPPGFPSPFLFPDGL | 601 | Q9UI36 | |
| LVPVPPLPEYGGKVR | 41 | P24539 | |
| PLVLFGPPGIGKTAL | 336 | Q149M9 | |
| FLGIPFAKPPLGPLR | 51 | Q9UKY3 | |
| FAKPPLGPLRFTLPQ | 56 | Q9UKY3 | |
| VFAGGPVPLPPVKFV | 586 | Q9HBX8 | |
| LLLPGPFPGKDPAFS | 146 | Q2KJY2 | |
| SAPFPRPKFGRPLKP | 281 | Q9P266 | |
| PSKPPFRFGQPSLFG | 26 | O60318 | |
| RLLQPFQPGSKPPFL | 341 | Q9H165 | |
| FGPKLPPSLGNKPVL | 1131 | Q9UKJ3 | |
| KFDLTGIPPAPRGVP | 461 | P54652 | |
| SPPGLRGFPFRTPLK | 86 | Q5JX69 | |
| QTFLGIPFAKPPLGP | 56 | O00748 | |
| IPFAKPPLGPLRFAP | 61 | O00748 | |
| PLFPKPAFGQKPPLS | 191 | O15117 | |
| PLLCPPGAFLPGLKA | 2041 | Q9UM47 | |
| FLGPPPPPLLLLVFS | 16 | A6NEC2 | |
| IPPGVPLPSKFTLLF | 166 | Q9UHB4 | |
| VFPGLLSLPGIPGFP | 866 | Q86XN7 | |
| TFKPGAFIPGVPVQP | 231 | Q7L5N7 | |
| KVGVAAPPFLGSPVP | 86 | Q9BRQ0 | |
| LPPFLGVPKPGLYPL | 1041 | O14559 | |
| ALPPKPQGPFSIRAG | 5021 | Q4G0P3 | |
| IPGAPQPIPRLFFAG | 786 | O60341 | |
| PPKPLKNPRLGDFYG | 16 | Q0VDD7 | |
| KLGFFPDPRPFPLPL | 2791 | P51587 | |
| PPARFGAQKGPIPSL | 1796 | Q9BTC0 | |
| VPLPPPGRSLKFYGV | 236 | Q6ZUT9 | |
| VPLPPPGRSLKFSGV | 251 | Q6IQ26 | |
| FEKFGPGPAPIPRLI | 86 | Q502W7 | |
| GGPFIPAAPVKTALP | 426 | Q7Z7F0 | |
| LPGRVFFLKPLRPVP | 271 | Q86UW8 | |
| ELLGGPSVFLFPPKP | 116 | P01857 | |
| APELLGGPSVFLFPP | 161 | P01860 | |
| GGPSVFLFPPKPKDT | 166 | P01860 | |
| GGPSVFLFPPKPKDT | 116 | P01861 | |
| LPGAFKPDILLPGPR | 261 | Q6ZN32 | |
| LPPGIPFRKPCTFGS | 746 | Q9UHL9 | |
| FLGPPPPPLLLLVFS | 16 | P55786 | |
| PLQGAVIPGPPFLFG | 421 | Q5SR56 | |
| KQPPRPFRSFVPGPL | 2191 | A6NMZ7 | |
| ISGIFRPKFSLPPPL | 431 | P07332 | |
| PLAKRAAPLAFPPLG | 246 | Q92570 | |
| IEPPKGVLLFGPPGT | 206 | P35998 | |
| PGPTGPIKIFPFKSL | 96 | Q8N1F8 | |
| PVPSKGFGLLQKLPP | 376 | P84550 | |
| GFGLLQKLPPPLFPH | 381 | P84550 | |
| QPEFFGDLPRKPPLP | 371 | Q96QH2 | |
| PRGKPIFPVYPLVGS | 726 | A6NEL2 | |
| RLLQPPKGVLLYGPP | 121 | Q8NBU5 | |
| SGFLPPITPPEKFFL | 171 | Q9UKZ1 | |
| PPPLFSVIPGGFIKQ | 26 | Q8IUG5 | |
| PAGSGPKPFLFSLPQ | 516 | Q9HC78 | |
| LPKGFVIGTEPLPGP | 11 | F5GYI3 | |
| AGGILPFGKPDPLPT | 141 | A8MV72 | |
| PFGVKAALPPRASGP | 161 | B2RXF5 | |
| PPPPGFSAVVLLKGT | 681 | Q86UK7 | |
| AGGILPFGKPDPLPT | 171 | Q8N9G6 | |
| AGGILPFGKPDPLPT | 171 | A8MUA0 | |
| GGILPFGKPDPLPAV | 171 | A6NL46 | |
| VFPKSLGPPGPPFNI | 1766 | Q9NZM1 |